CI Stock Summary and Trading Ideas (Cigna Group | NYSE:CI)

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.

Cigna Group trades on the NYSE stock market under the symbol CI.

As of April 19, 2024, CI stock price climbed to $351.44 with 654,358 million shares trading.

CI has a beta of 0.31, meaning it tends to be less sensitive to market movements. CI has a correlation of 0.02 to the broad based SPY ETF.

CI has a market cap of $99.69 billion. This is considered a Large Cap stock.

Last quarter Cigna Group reported $51 billion in Revenue and $6.79 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $.26.

In the last 3 years, CI stock traded as high as $365.71 and as low as $191.74.

The top ETF exchange traded funds that CI belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.

CI has outperformed the market in the last year with a price return of +37.3% while the SPY ETF gained +21.4%. CI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +14.2% and -2.5%, respectively, while the SPY returned +4.5% and -3.3%, respectively.

CI support price is $345.20 and resistance is $352.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CI stock will trade within this expected range on the day.